Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates.

about

Mocetinostat combined with gemcitabine for the treatment of leiomyosarcoma: Preclinical correlates.

Item

http://www.wikidata.org/entity/Q47130359

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Mocetinostat combined with gem ...... rcoma: Preclinical correlates.

@en

Mocetinostat combined with gem ...... rcoma: Preclinical correlates.

@nl

type

Item

label

Mocetinostat combined with gem ...... rcoma: Preclinical correlates.

@en

Mocetinostat combined with gem ...... rcoma: Preclinical correlates.

@nl

prefLabel

Mocetinostat combined with gem ...... rcoma: Preclinical correlates.

@en

Mocetinostat combined with gem ...... rcoma: Preclinical correlates.

@nl

P1476

Mocetinostat combined with gem ...... arcoma: Preclinical correlates

@en

P2093

Abeba Zewdu

http://www.w3.org/2001/XMLSchema#string

Anne Strohecker

http://www.w3.org/2001/XMLSchema#string

Danielle Braggio

http://www.w3.org/2001/XMLSchema#string

David Koller

http://www.w3.org/2001/XMLSchema#string

Dina Lev

http://www.w3.org/2001/XMLSchema#string

Edwin Choy

http://www.w3.org/2001/XMLSchema#string

Hemant Kumar Bid

http://www.w3.org/2001/XMLSchema#string

Kara Batte

http://www.w3.org/2001/XMLSchema#string

Lucia Casadei

http://www.w3.org/2001/XMLSchema#string

Obiajulu Hans Iwenofu

http://www.w3.org/2001/XMLSchema#string

P2860

The many roles of histone deacetylases in development and physiology: implications for disease and therapy

New and emerging HDAC inhibitors for cancer treatment

DNA methylation-independent reversion of gemcitabine resistance by hydralazine in cervical cancer cells

Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research

Drug combination studies and their synergy quantification using the Chou-Talalay method

Functional consequences of histone modifications.

Suberoylanilide hydroxamic acid combined with gemcitabine enhances apoptosis in non-small cell lung cancer.

Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial.

Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial.

Advances in characterization of human sirtuin isoforms: chemistries, targets and therapeutic applications.

P304

e0188859

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0188859

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Gonzalo Lopez

P577

2017-11-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29186204

http://www.w3.org/2001/XMLSchema#string

P932

5706733

http://www.w3.org/2001/XMLSchema#string